About In2Bones
In2Bones is a Healthcare company based in Ecully (France) founded in 2011, and was acquired by CONMED in June 2022. Provider of single use surgical instruments and orthopedic implants for use in lower extremity surgeries. In2Bones has raised $5.6 million across 2 funding rounds from investors including CONMED and Newfund. In2Bones offers products and services including Extremity Medical Devices. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Surgical Tools. Its legal entity is In2Bones SAS.
Company details
Provider of single-use surgical instruments and orthopedic implants for use in lower extremity surgeries. It sells its products in the form of modular kits that contain all the implants and instruments for a particular surgical procedure. The kits contain instruments like Burrs, Bone plates, Foot endorthesis, Bone synthesis, Scres, and other instruments in various sizes and specifications.
- Headquarters Ecully, France
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website in2bones.com
- Social LinkedIn X
- Acquired by CONMED (Jun 2022)
- Legal Name In2bones Sas
Products & Services of In2Bones
In2Bones offers a comprehensive portfolio of products and services, including Extremity Medical Devices.
Devices designed for extremity treatments in healthcare settings.
Funding Insights of In2Bones
In2Bones has successfully raised a total of $5.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.5 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.6M
- Total Rounds 2
- Last Round Series A — $1.5M
- First Round $4.1M
(Feb 2014)
- Investors Count 1
All 2 funding rounds of In2Bones with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2017 | $1.5M | Series A | – | – | – |
| Feb 2014 | $4.1M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in In2Bones
In2Bones has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CONMED and Newfund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage VC firm investing in geographies such as the US & France | newfundcap.com | Paris, France | ||
Surgical instruments are manufactured for multiple therapeutic areas. | 1987 | conmed.com | Utica, United States |
Investor details for In2Bones
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of In2Bones
4 dated milestones of In2Bones across 11 years, from founding to its latest funding, stage changes and deals.
- Founded In2Bones is founded.
- Funding First funding round of $4.1M.
- Funding Latest funding round, Series A, of $1.5M.
- Exit Acquired by CONMED.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about In2bones
Complete news archive for In2Bones
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about In2Bones
In2Bones was founded in 2011 and raised its 1st funding round 3 years after it was founded.
In2Bones is headquartered in Ecully, France. It is registered at Ecully, Auvergne-rhone-alpes, France.
In2Bones is a funded company, having raised a total of $5.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.1M, raised on Feb 2014.
Provider of single-use surgical instruments and orthopedic implants for use in lower extremity surgeries. It sells its products in the form of modular kits that contain all the implants and instruments for a particular surgical procedure. The kits contain instruments like Burrs, Bone plates, Foot endorthesis, Bone synthesis, Scres, and other instruments in various sizes and specifications.
In2Bones offers Extremity Medical Devices.
In2Bones operates through In2bones Sas.
Yes. In2Bones was acquired by CONMED in June 2022.